Hill, Mitch C.'s Form 4 filing
Inari Medical, Inc.NARI · filed Sep 13, 2024
- Accession no.
- 0001127602-24-023899
- Filed
- Sep 13, 2024, 4:35 PM ET
- Trade date
- Sep 12, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $135.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hill, Mitch C.CIK 0001644989 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | MOption exerciseAcquired | +3,000 | $0.457 | +$1,371 | 182,600 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −1,609 | $44.38F2 | −$71,407.42 | 180,991 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −891 | $45.80F3 | −$40,807.8 | 180,100 | Direct | |
| Sep 12, 2024 | Common Stock | SSaleDisposed | −500 | $46.34F4 | −$23,170 | 179,600 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2024 | Common Stock | MOption exerciseDisposed | −3,000 | $0.00 | $0 | 58,477 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $44.13 to $44.95. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F3
This transaction was executed in multiple trades at prices ranging from $45.24 to $46.23. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $46.24 to $46.53. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.